Drug settlement deals under EU spotlight
The European Commission has asked originator and generic drugs companies to hand over copies of settlement deals they have agreed over the past 18 months
It has not revealed which companies have been sent the requests for information, but the requests cover patent settlement deals struck between July 1 2008 and December 31 last year covering the EU and European Economic Area.
The Commission said...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.